Tofacitinib Impurity 191

Tofacitinib Impurity 191 Struktur
1638499-36-1
CAS-Nr.
1638499-36-1
Englisch Name:
Tofacitinib Impurity 191
Synonyma:
Tofacitinib Impurity 191;N-(1-benzyl-4-methyl-1,2,5,6-tetrahydropyridin-3-yl)acetamide;Acetamide, N-[1,2,5,6-tetrahydro-4-methyl-1-(phenylmethyl)-3-pyridinyl]-
CBNumber:
CB55849542
Summenformel:
C15H20N2O
Molgewicht:
244.33
MOL-Datei:
1638499-36-1.mol

Tofacitinib Impurity 191 Eigenschaften

Siedepunkt:
427.4±45.0 °C(Predicted)
Dichte
1.09±0.1 g/cm3(Predicted)
pka
15.53±0.20(Predicted)

Sicherheit

Tofacitinib Impurity 191 Chemische Eigenschaften,Einsatz,Produktion Methoden

Tofacitinib Impurity 191 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Tofacitinib Impurity 191 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
ChemStrong Scientific Co.,Ltd 0755-0755-66853366 13670046396
sales@chem-strong.com China 18021 56
Jinan blalong chemical co. LTD 2710913286@.com
1513643261@qq.com China 14253 58
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd 15850510341
shiqingran@wzxchem.com China 3639 58
Nanjing Huanuo Biomedical Technology Co., Ltd 18913906212
2885426135@qq.com China 6789 58
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725
malulu@leyan.com China 39990 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016; 18162595016
3287908757@qq.com China 9116 58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd 18102736234 18102736234
2208093734@qq.com China 7664 58
Nantong Hanfang Biotechnology Co. , Ltd. 18616537568
hanfangpharma@126.com China 30968 58

1638499-36-1()Verwandte Suche:


  • Tofacitinib Impurity 191
  • Acetamide, N-[1,2,5,6-tetrahydro-4-methyl-1-(phenylmethyl)-3-pyridinyl]-
  • N-(1-benzyl-4-methyl-1,2,5,6-tetrahydropyridin-3-yl)acetamide
  • 1638499-36-1
Copyright 2019 © ChemicalBook. All rights reserved